Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia
Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia
Recruiting · NCT06392711 · Registry updated 2026-08-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia | Sjogren syndrome, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Xerostomia, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, dry eye syndrome, eye disorder, graft versus host disease, immune system disorder, lacrimal apparatus disorder, mouth disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis, salivary gland disorder | Recruiting | Phase 1 | 2026-08-19 | NCT06392711 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Wisconsin, Madison | 265 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Wisconsin | Madison | United States | 64 |